Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT00268216 · COMPLETED

Trial details

NCT number: NCT00268216
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2000-09-01
Primary completion: 2005-11-01
Enrollment: 6228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.